ETON
Eton Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$55.50
−2.75%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$57.51
From 52W high−13.86%
Volume829590.00
Market cap$1.59B
P/E (TTM)119.4x
P/S (TTM)15.0x
Div yield—
Key dataSep 18, 2026
Open
$57.51
From 52W high
−13.86%
Volume
829590.00
Market cap
$1.59B
ValuationView details →
P/E (Fwd)
37.3x
EV/EBITDA
85.6x
P/E (TTM)
119.4x
RSI (14)
51.1
MomentumView details →
1D Return
−2.75%
YTD Return
+234.79%
SummaryUpdated Jun 1, 2026
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is a specialty pharmaceutical company founded in 2017 and based in Deer Park, Illinois. The company went public in November 2018 and focuses on developing and commercializing pharmaceutical products for rare diseases, particularly those affecting fewer than 10,000 patients in the United States. Since its inception, Eton has transformed from a development-stage company into a commercial enterprise with multiple approved products, achieving consistent revenue growth and reaching near-profitability by 2024.
Similar companies
Latest newsMore news →